Skip to main content

Table 4 Safety information by treatment arm

From: Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial

Treatment AL, n = 193 ASAQ, n = 188 P-value
Total number of adverse events (AE) 386 346
Mean AEs per patient 2 1.8 0.20
Severity of adverse events (%)
 Mild 83.4 84.7 0.642
 Moderate 13.7 13.9 0.956
 Serious 2.9 1.4 0.382
Relationship of events with the treatment (%)
 Definitely unrelated 29.5 30.3 0.810
 Unlikely 54.2 55.2 0.774
 Possible 12.7 10.7 0.401
 Probable 3.6 3.8 0.926
 Definitely related 0 0